Updated daily
# | PubMedId | Deleted | Publication |
---|---|---|---|
39479325 | 0 | Leong DP, Fradet V, Niazi T, et al. Adiposity and Muscle Strength in Men With Prostate Cancer and Cardiovascular Outcomes. JACC CardioOncol. 2024 Sep 3;6(5):761-771. doi: 10.1016/j.jaccao.2024.07.011. eCollection 2024 Oct. | |
38961717 | 0 | Antonelli L, Wendel-Garcia PD, Deforth M, et al. Thromboprophylaxis during neoadjuvant chemotherapy for bladder cancer reduces thromboembolism and bleeding. BJU Int. 2024 Nov;134(5):781-788. doi: 10.1111/bju.16444. Epub 2024 Jul 3. | |
35621286 | 0 | Amenyogbe A, Lemire F, Yachnin D, et al. A survey of physician perception and practices regarding pharmacological thromboprophylaxis during chemotherapy for bladder cancer. Can Urol Assoc J. 2022 May 20. pii: cuaj.7865. doi: 10.5489/cuaj.7865. | |
35581123 | 0 | Garas SN, McAlpine K, Ross J, et al. Venous thromboembolism risk in patients receiving neoadjuvant chemotherapy for bladder cancer. Urol Oncol. 2022 May 14. pii: S1078-1439(22)00116-8. doi: 10.1016/j.urolonc.2022.04.006. | |
34556430 | 0 | Shiff B, Breau RH, Mallick R, et al. Prognostic significance of extent of venous tumor thrombus in patients with non-metastatic renal cell carcinoma: Results from a Canadian multi-institutional collaborative. Urol Oncol. 2021 Dec;39(12):836.e19-836.e27. doi: 10.1016/j.urolonc.2021.08.016. Epub 2021 Oct 20. | |
34438079 | 0 | McAlpine K, Breau RH, Werlang P, et al. Timing of Perioperative Pharmacologic Thromboprophylaxis Initiation and its Effect on Venous Thromboembolism and Bleeding Outcomes: A Systematic Review and Meta-Analysis. J Am Coll Surg. 2021 Nov;233(5):619-631.e14. doi: 10.1016/j.jamcollsurg.2021.07.687. Epub 2021 Aug 24. | |
34129893 | 0 | Lavi A, Breau RH, Mallick R, et al. Adrenalectomy During Radical Nephrectomy- Incidence and Oncologic Outcomes From the Canadian Kidney Cancer Information System (CKCis) -A Modern Era, Nationwide, Multicenter Cohort. Urology. 2021 Nov;157:168-173. doi: 10.1016/j.urology.2021.05.053. Epub 2021 Jun 12. | |
33253514 | 0 | McAlpine K, Breau R, Carrier M, et al. Thromboprophylaxis practice patterns and beliefs among physicians treating patients with abdominopelvic cancers at a Canadian centre. Can J Surg. 2020 Nov 30;63(6):E562-E568. doi: 10.1503/cjs.015219. | |
32334825 | 0 | McAlpine K, Lavallee LT. Reply to: Re: Venous thromboembolism and transfusion after major abdominopelvic surgery. Surgery. 2020 Jun;167(6):1026. doi: 10.1016/j.surg.2020.02.030. Epub 2020 Apr 22. | |
31377000 | 0 | McAlpine K, Breau RH, Knee C, et al. Venous thromboembolism and transfusion after major abdominopelvic surgery. Surgery. 2019 Dec;166(6):1084-1091. doi: 10.1016/j.surg.2019.05.050. Epub 2019 Jul 31. | |
30840115 | 0 | Klaassen Z, Wallis CJD, Lavallee LT, et al. Perioperative venous thromboembolism prophylaxis in prostate cancer surgery. World J Urol. 2020 Mar;38(3):593-600. doi: 10.1007/s00345-019-02705-x. Epub 2019 Mar 6. | |
30505737 | 0 | McAlpine K, Lavallee LT. Decreasing rates of venous thromboembolism after radical cystectomy: an encouraging trend and more work is still needed. Transl Androl Urol. 2018 Dec;7(6):982-983. doi: 10.21037/tau.2018.07.15. | |
29567052 | 0 | Montroy J, Hutton B, Moodley P, et al. The efficacy and safety of topical tranexamic acid: A systematic review and meta-analysis. Transfus Med Rev. 2018 Feb 19. pii: S0887-7963(17)30151-7. doi: 10.1016/j.tmrv.2018.02.003. | |
28366637 | 0 | Montroy J, Fergusson NA, Hutton B, et al. The Safety and Efficacy of Lysine Analogues in Cancer Patients: A Systematic Review and Meta-Analysis. Transfus Med Rev. 2017 Jul;31(3):141-148. doi: 10.1016/j.tmrv.2017.03.002. Epub 2017 Mar 22. | |
28214280 | 0 | McAlpine K, Breau RH, Mallick R, et al. Current guidelines do not sufficiently discriminate venous thromboembolism risk in urology. Urol Oncol. 2017 Jul;35(7):457.e1-457.e8. doi: 10.1016/j.urolonc.2017.01.015. Epub 2017 Feb 15. |